Transposon Therapeutics
Transposon Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformational therapies for neurodegenerative and aging-related diseases driven by LINE-1 retrotransposon activity. Its lead asset, TPN-101 (censavudine), is a potent oral inhibitor of LINE-1 reverse transcriptase in late-stage development for progressive supranuclear palsy (PSP), amyotrophic lateral sclerosis (ALS) / frontotemporal dementia (FTD), and Alzheimer's disease. The pipeline also includes follow-on novel nucleoside reverse transcriptase inhibitors (NRTIs) and Protein Kinase R inhibitors (PKRi) targeting pathways activated by LINE-1 and implicated in cognitive impairment. Surfaced as a portfolio company of Canaan Partners and added to the API Evangelist network; enrichment found a corporate marketing website only and no public API, developer, or machine-readable surface.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Transposon Therapeutics the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Transposon Therapeutics scores 14.6/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Transposon Therapeutics
Each block below is one kind of artifact we hold for Transposon Therapeutics. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Transposon Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/transposon-therapeutics · machine-readable index on apis.io